How to Get Synthroid in Maryland: Prescriptions, Telehealth, and Pharmacies

What Is Synthroid and Why Does It Require a Prescription?

Synthroid is the brand-name formulation of levothyroxine sodium, a synthetic form of the T4 thyroid hormone. The FDA classifies levothyroxine as a narrow therapeutic index (NTI) drug, meaning small differences in dose or bioavailability can cause clinically significant effects [1]. Because of this, every formulation change, manufacturer switch, or generic substitution should involve physician oversight. A prescription is mandatory under federal and Maryland state law.

The American Thyroid Association (ATA) 2014 guidelines define overt hypothyroidism as a TSH above the upper reference limit combined with a low Free T4, and they recommend initiating levothyroxine therapy in all such patients [2]. Subclinical hypothyroidism (elevated TSH, normal Free T4) may also warrant treatment depending on symptom burden, TSH level above 10 mIU/L, pregnancy status, or cardiovascular risk factors [2].

Hypothyroidism affects an estimated 4.6% of the U.S. population aged 12 and older, based on data from the National Health and Nutrition Examination Survey [3]. Left untreated, it raises LDL cholesterol, impairs cardiac function, and in pregnant women raises the risk of preterm birth and neurodevelopmental delay in the fetus [4]. Treatment is typically lifelong, so choosing a reliable Maryland prescriber and pharmacy is a long-term decision.

Who Can Prescribe Synthroid in Maryland?

Maryland law grants full prescriptive authority to several license categories, and knowing this matters when choosing a telehealth platform.

In Maryland, the following clinicians may independently prescribe Synthroid:

• MDs and DOs: Unlimited prescriptive authority under Maryland Health Occupations Article §14.
• Nurse Practitioners (NPs): Maryland granted NPs full practice authority effective October 1, 2023. NPs may now prescribe Schedule II through V controlled substances and all non-controlled medications, including levothyroxine, without a physician collaboration agreement.
• Physician Assistants (PAs): PAs in Maryland prescribe under a delegation agreement with a supervising physician. That agreement must list the categories of drugs the PA may prescribe; levothyroxine is routinely included.

Telehealth platforms operating in Maryland must hold a valid Maryland business registration and employ clinicians licensed by the Maryland Board of Physicians, the Maryland Board of Nursing, or the Maryland Board of Physicians (for PAs). Patients should verify licensure before scheduling. The Maryland Department of Health maintains a public license-verification portal at health.maryland.gov.

What Labs Are Required Before Getting a Synthroid Prescription in Maryland?

A TSH measurement is the single non-negotiable lab. TSH is the most sensitive marker of thyroid status and is the primary diagnostic tool recommended in the ATA 2014 guidelines [2]. Most telehealth platforms accept results from any CLIA-certified laboratory, including LabCorp, Quest Diagnostics, and independent Maryland labs, provided results are dated within three to six months.

A serum Free T4 is commonly ordered alongside TSH to distinguish between primary and central (secondary or tertiary) hypothyroidism. In primary hypothyroidism, TSH is high and Free T4 is low. In central hypothyroidism, both may be low, which changes the clinical approach entirely [5].

Additional labs a Maryland clinician may order include:

• TPO antibodies (anti-thyroid peroxidase): Elevated in Hashimoto's thyroiditis, the most common cause of hypothyroidism in iodine-sufficient regions. A 2020 meta-analysis covering 13 studies found TPO antibody positivity in 7.5% of the general population [6].
• Thyroglobulin antibodies: Ordered when TPO is negative but autoimmune etiology is still suspected.
• Complete metabolic panel (CMP) and lipid panel: Hypothyroidism elevates total cholesterol and LDL. Baseline values help the clinician monitor treatment response.
• Complete blood count (CBC): Macrocytic anemia can accompany hypothyroidism caused by concurrent vitamin B12 deficiency, particularly in autoimmune cases.

Bring any prior thyroid lab results to your first appointment. A clinician who can see TSH trend data over months makes a more precise dosing decision than one working from a single data point [2].

How to Get a Synthroid Prescription Through Telehealth in Maryland

Maryland explicitly permits telemedicine prescribing under the Maryland Telemedicine Act and the COMAR 10.32.04 regulations. An audio-visual visit qualifies as a valid patient-physician encounter for purposes of establishing a prescriber-patient relationship, which is the legal prerequisite for issuing any prescription.

The typical telehealth pathway in Maryland runs as follows:

1. Order labs (or upload recent results). TSH at minimum; most platforms prefer Free T4 as well. Results take 24 to 72 hours from a walk-in lab draw.
2. Complete an intake form covering symptoms (fatigue, cold intolerance, weight gain, constipation, brain fog), medication history, allergies, and current supplements such as calcium or iron that can reduce levothyroxine absorption.
3. Attend a video or phone visit with the prescribing clinician, typically 15 to 30 minutes for an initial hypothyroidism evaluation.
4. Receive the electronic prescription, usually within 24 hours of the visit. Maryland participates in the PDMP (Prescription Drug Monitoring Program), though levothyroxine is a non-controlled substance and does not require PDMP query.
5. Pick up or receive delivery from a Maryland-licensed pharmacy of your choice. Most major chains have same-day dispensing.

The FDA Drug Safety Communication on levothyroxine products recommends that clinicians avoid switching patients between formulations without re-testing TSH six weeks after any change, because bioavailability differs slightly across manufacturers [1]. When filling through telehealth, ask the prescriber to note "dispense as written" (DAW) if brand-name Synthroid is specifically indicated.

The HealthRX Maryland Thyroid Intake Framework standardizes pre-visit documentation for telehealth hypothyroidism evaluations. Clinicians using this framework collect: (1) TSH and Free T4 with reference ranges from the performing lab, (2) a 10-symptom checklist weighted by ATA criteria, (3) medication and supplement list screened for nine known levothyroxine absorption interactions, and (4) a cardiovascular risk snapshot (resting heart rate, blood pressure if available, prior arrhythmia history). Patients who complete all four components before the video visit reduce average consult time by approximately 40% compared with those who arrive without pre-visit documentation, based on internal HealthRX platform data.

Synthroid Dosing: What to Expect at Initiation

Starting doses vary by age, weight, cardiac status, and severity of hypothyroidism. The ATA guidelines recommend full replacement dosing of approximately 1.6 mcg/kg/day for most healthy adults under age 65 with overt hypothyroidism [2]. For a 70 kg adult, that translates to roughly 112 mcg/day.

Older adults and patients with known or suspected coronary artery disease start at lower doses, typically 25 to 50 mcg/day, with upward titration every four to six weeks based on TSH response. The NEJM review of thyroid hormone therapy notes that cardiac ischemia can be precipitated if a profoundly hypothyroid patient with underlying coronary disease is started at a full replacement dose [7].

Levothyroxine has a plasma half-life of approximately 6 to 7 days, meaning TSH stabilization takes four to six weeks after any dose change [7]. Patients should not expect symptom resolution overnight. Fatigue and cold intolerance often improve within the first two to four weeks; full cognitive and metabolic normalization may take three to six months in cases of long-standing hypothyroidism.

Follow-up TSH testing is recommended at six weeks after initiation, then at six months once stable, then annually. The ATA targets a TSH of 0.5 to 2.5 mIU/L for most patients, though the acceptable range shifts in pregnancy (0.1 to 2.5 mIU/L in the first trimester) [2].

Maryland Pharmacies for Synthroid: Retail, Mail-Order, and 503A Compounding

Any Maryland-licensed pharmacy may dispense levothyroxine. The Maryland Board of Pharmacy maintains a searchable license database. Major retail chains with statewide locations include CVS, Walgreens, Walmart Pharmacy, and Giant Food Pharmacy. Independent pharmacies are also common in Baltimore, Annapolis, Rockville, and Frederick.

Mail-order and 90-day supplies: Most commercial insurance plans and Maryland Medicaid managed care organizations allow 90-day supplies through mail-order pharmacies at a lower co-pay than 30-day retail fills. Because levothyroxine is taken daily for life, a 90-day supply reduces the cost-per-dose and the risk of a gap in therapy.

503A compounding pharmacies: A 503A compounding pharmacy in Maryland may prepare custom levothyroxine formulations (for example, liquid suspensions for patients with swallowing difficulties, or formulations that avoid specific excipients like acacia or lactose that some patients react to). The FDA's 2020 guidance on compounding of drug products that are essentially copies of commercially available products limits the circumstances under which a compounded levothyroxine is appropriate; the prescriber must document a clinical need that cannot be met by the commercial product [8]. Compounded levothyroxine is not bioequivalent-tested and lacks the stability data of FDA-approved tablets, so the ATA recommends commercial products as the first choice [2].

Cost without insurance: A 30-day supply of generic levothyroxine 100 mcg costs approximately $10 to $20 at major Maryland retail pharmacies using GoodRx or similar discount programs. Brand-name Synthroid 100 mcg runs $45 to $80 per month at retail without insurance.

Maryland Medicaid and Insurance Coverage for Synthroid

Maryland Medicaid (administered through HealthChoice managed care organizations) covers levothyroxine for hypothyroidism but requires prior authorization (PA) for Synthroid specifically, since lower-cost generics are preferred on the formulary. PA approval typically requires documentation of a TSH above the upper limit of normal, a diagnosis code of E03.9 (hypothyroidism, unspecified) or a more specific ICD-10 code, and in some cases evidence that the patient has failed or cannot use a generic formulation.

The Centers for Medicare and Medicaid Services (CMS) Part D formularies generally cover levothyroxine at Tier 1 (generic) or Tier 2 (brand), and Medicare beneficiaries in Maryland should compare plan formularies annually using the Medicare Plan Finder tool at medicare.gov [9].

Commercial insurers operating in Maryland, including CareFirst BlueCross BlueShield, Aetna, UnitedHealthcare, and Kaiser Permanente Mid-Atlantic, typically cover generic levothyroxine at Tier 1 with a $0 to $10 co-pay. Brand-name Synthroid usually sits at Tier 3 or requires a step-edit demonstrating medical necessity. A prescriber's note stating a clinical reason for brand over generic, such as documented TSH instability on multiple generics, generally satisfies this step-edit [10].

How to Transfer a Synthroid Prescription to a Maryland Pharmacy

Prescription transfers in Maryland are governed by COMAR 10.34.17. Key rules:

• Non-controlled prescriptions like levothyroxine may be transferred between any two Maryland-licensed pharmacies an unlimited number of times, unlike Schedule III-V controlled substances which are limited to one transfer.
• Out-of-state prescriptions for non-controlled drugs written by a practitioner licensed in another U.S. state are valid in Maryland if the prescriber holds a valid license in their home state.
• Electronic transfer is the most reliable method. Call the receiving pharmacy with the prescription number and the originating pharmacy's phone number; they handle the transfer directly.
• Refills transfer with the prescription. If 10 refills remain at the originating pharmacy, all 10 transfer.

Patients relocating to Maryland from another state should verify that their out-of-state prescriber is willing to continue the prescription remotely or plan a new consultation with a Maryland-licensed clinician within the first refill cycle.

Special Populations in Maryland: Pregnancy, Pediatrics, and Older Adults

Pregnancy: The Endocrine Society's 2017 clinical practice guideline on thyroid disease in pregnancy recommends trimester-specific TSH targets: <2.5 mIU/L in the first trimester and <3.0 mIU/L in the second and third trimesters [11]. Levothyroxine requirements increase by 25 to 50% during pregnancy, often within the first four to six weeks of gestation. Maryland ob-gyns and maternal-fetal medicine specialists routinely co-manage hypothyroidism with endocrinologists or primary care during pregnancy.

Pediatrics: Children with congenital hypothyroidism identified through Maryland's mandatory newborn screening program are treated with levothyroxine starting within the first two weeks of life. Neonatal dosing begins at 10 to 15 mcg/kg/day and is adjusted based on TSH and Free T4 normalization [12]. The Maryland Department of Health's Hereditary and Congenital Disorders Program coordinates follow-up for these infants.

Older adults: Adults over 65 with subclinical hypothyroidism (TSH 4.5 to 10 mIU/L, normal Free T4) may not benefit from treatment. The TRUST randomized controlled trial (N=737, mean age 74.4 years) found that levothyroxine treatment in older adults with subclinical hypothyroidism produced no significant improvement in the Hypothyroid Symptom Score or Tiredness Score compared with placebo at one year [13]. Maryland clinicians treating older patients should weigh symptom burden against the risks of over-treatment, including atrial fibrillation and bone loss.

Drug Interactions That Maryland Prescribers Check Before Writing the Prescription

Levothyroxine absorption is reduced by several common medications and supplements. The FDA product label lists the following as requiring separation by at least four hours from levothyroxine [1]:

• Calcium carbonate and calcium citrate supplements
• Antacids containing aluminum, magnesium, or calcium (Tums, Maalox, Mylanta)
• Iron salts (ferrous sulfate, ferrous gluconate)
• Cholestyramine and colestipol
• Proton pump inhibitors (omeprazole, pantoprazole), which raise gastric pH and reduce tablet dissolution
• Soy-based foods and infant soy formula in high quantities

Drugs that increase levothyroxine metabolism and may require dose increases include rifampin, carbamazepine, phenytoin, and phenobarbital [1]. Amiodarone, which contains 37% iodine by weight, can cause both hypothyroidism and hyperthyroidism and requires close TSH monitoring when started or stopped in a patient on levothyroxine [7].

Frequently Asked Questions